April 19, 2024 Bitcoin Halving: Catalyst for New Price Heights?
April 18, 2024 EU Moves Toward Single Capital Market Union
April 17, 2024 Bitcoin Halving 2024: Market Impact Predictions
April 14, 2024 Markets Rattle: Iran-Israel Conflict and Economic Data Ahead
Apple’s Technical Climb To $240 By Year-End
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
March 6, 2024 Navigating GBP Forecast: Mistakes To Avoid In Forex Trading
Pasithea Therapeutics (KTTA) stock forecast for 2024
Updated: April 16, 2024 (17:21)
Sector: HealthcareThe share price of Pasithea Therapeutics Corp. (KTTA) now
50/200 Day Moving Average: $7.23 / $8.48
This figure corresponds to the Average Price over the previous 50/200 days. For Pasithea Therapeutics stocks, the 50-day moving average is the resistance level today.
For Pasithea Therapeutics stocks, the 200-day moving average is the resistance level today.
Are you interested in Pasithea Therapeutics Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Pasithea Therapeutics stock price in 2024. How much will one Pasithea Therapeutics share be worth in 2024? Is it worth taking profit / loss on KTTA stock now or waiting? What are analysts' forecasts for Pasithea Therapeutics stock?
We forecast Pasithea Therapeutics stock performance using neural networks based on historical data on KTTA stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Pasithea Therapeutics Corp. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Pasithea Therapeutics analysts is $2. Today 200 Day Moving Average is the resistance level (8.48 $). 50 Day Moving Average is the support level (7.23 $).
Historical and forecast chart of Pasithea Therapeutics Corp. stock
The chart below shows the historical price of Pasithea Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the KTTA stock price can be found in the table below.
Pasithea specializes in the discovery and development of new drugs for the treatment of psychiatric and neurological disorders. The company does not currently have a leading candidate drug in development. In the 24 months following its IPO, the company plans to discover three leading candidate compounds targeting the immune system’s link to certain mental disorders. An additional Pasithea business is to open depression clinics in the UK and the US, where doctors will administer ketamine intravenously to patients when indicated.
Pasithea Therapeutics (KTTA) Forecast for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May | 8.14 | 7.20 | 8.57 | 15.96 % |
| Jun | 8.67 | 7.96 | 10.04 | 20.68 % |
| Jul | 9.27 | 8.51 | 10.40 | 18.16 % |
| Aug | 8.26 | 7.24 | 9.37 | 22.77 % |
| Sep | 8.48 | 8.13 | 8.86 | 8.25 % |
| Oct | 9.13 | 7.78 | 10.26 | 24.10 % |
| Nov | 10.45 | 9.07 | 12.12 | 25.17 % |
| Dec | 10.30 | 8.91 | 11.14 | 19.99 % |
Pasithea Therapeutics information and performance
2110 NARCISSUS CT, VENICE, CA, US
Market capitalization of the Pasithea Therapeutics Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of KTTA shares in the company outstanding by the market price of one share.
EBITDA of Pasithea Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Pasithea Therapeutics price target for 2024 by month
Target values for the price of one Pasithea Therapeutics share for May 2024.
In May, the Positive dynamics for Pasithea Therapeutics Corp. shares will prevail with possible monthly volatility of 15.962% volatility is expected.
Pessimistic target level: 7.20
Optimistic target level: 8.57
Target values for the price of one Pasithea Therapeutics share for Jun 2024.
In Jun, the Positive dynamics for Pasithea Therapeutics Corp. shares will prevail with possible monthly volatility of 20.682% volatility is expected.
Pessimistic target level: 7.96
Optimistic target level: 10.04
Target values for the price of one Pasithea Therapeutics share for Jul 2024.
In Jul, the Positive dynamics for Pasithea Therapeutics Corp. shares will prevail with possible monthly volatility of 18.158% volatility is expected.
Pessimistic target level: 8.51
Optimistic target level: 10.40
Target values for the price of one Pasithea Therapeutics share for Aug 2024.
In Aug, the Negative dynamics for Pasithea Therapeutics Corp. shares will prevail with possible monthly volatility of 22.770% volatility is expected.
Pessimistic target level: 7.24
Optimistic target level: 9.37
Target values for the price of one Pasithea Therapeutics share for Sep 2024.
In Sep, the Positive dynamics for Pasithea Therapeutics Corp. shares will prevail with possible monthly volatility of 8.246% volatility is expected.
Pessimistic target level: 8.13
Optimistic target level: 8.86
Target values for the price of one Pasithea Therapeutics share for Oct 2024.
In Oct, the Positive dynamics for Pasithea Therapeutics Corp. shares will prevail with possible monthly volatility of 24.104% volatility is expected.
Pessimistic target level: 7.78
Optimistic target level: 10.26
Target values for the price of one Pasithea Therapeutics share for Nov 2024.
In Nov, the Positive dynamics for Pasithea Therapeutics Corp. shares will prevail with possible monthly volatility of 25.172% volatility is expected.
Pessimistic target level: 9.07
Optimistic target level: 12.12
Target values for the price of one Pasithea Therapeutics share for Dec 2024.
In Dec, the Negative dynamics for Pasithea Therapeutics Corp. shares will prevail with possible monthly volatility of 19.993% volatility is expected.
Pessimistic target level: 8.91
Optimistic target level: 11.14
